NH SPAC (Korea) Today
| 206640 Stock | KRW 15,760 40.00 0.25% |
Performance0 of 100
| Odds Of DistressLess than 9
|
NH SPAC is trading at 15760.00 as of the 22nd of November 2024, a 0.25% down since the beginning of the trading day. The stock's open price was 15800.0. NH SPAC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for NH SPAC 2 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon, South Korea. Boditech is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 23.19 M outstanding shares. More on NH SPAC 2
Moving together with 206640 Stock
Moving against 206640 Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
206640 Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NH SPAC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NH SPAC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ui Choi |
| Business Concentration | Health Care, Health Care Equipment & Supplies (View all Sectors) |
NH SPAC 2 (206640) is traded on KOSDAQ in Korea and employs 354 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 269.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NH SPAC's market, we take the total number of its shares issued and multiply it by NH SPAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NH SPAC 2 has 23.19 M outstanding shares.
NH SPAC 2 has accumulated about 38.81 B in cash with 49.93 B of positive cash flow from operations.
Check NH SPAC Probability Of Bankruptcy
Ownership AllocationNH SPAC 2 secures a total of 23.19 Million outstanding shares. NH SPAC 2 shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check 206640 Ownership Details
NH SPAC 2 Risk Profiles
Although NH SPAC's alpha and beta are two of the key measurements used to evaluate NH SPAC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.1 | |||
| Standard Deviation | 3.25 | |||
| Variance | 10.55 | |||
| Risk Adjusted Performance | (0.04) |
206640 Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in NH SPAC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
NH SPAC Corporate Directors
Other Information on Investing in 206640 Stock
NH SPAC financial ratios help investors to determine whether 206640 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 206640 with respect to the benefits of owning NH SPAC security.